Atea Pharmaceuticals Stock Performance

AVIR -  USA Stock  

USD 24.78  0.33  1.31%

The firm shows a Beta (market volatility) of 0.0455, which signifies not very significant fluctuations relative to the market. Let's try to break down what Atea Pharmaceuticals's beta means in this case. As returns on the market increase, Atea Pharmaceuticals returns are expected to increase less than the market. However, during the bear market, the loss on holding Atea Pharmaceuticals will be expected to be smaller as well. Even though it is essential to pay attention to Atea Pharmaceuticals historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Atea Pharmaceuticals exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Atea Pharmaceuticals has an expected return of -0.29%. Please be advised to confirm Atea Pharmaceuticals maximum drawdown, and the relationship between the information ratio and expected short fall to decide if Atea Pharmaceuticals performance from the past will be repeated at some point in the near future.

Search Stock Performance 

 
Refresh
 Atea Pharmaceuticals Performance
0 of 100
Over the last 90 days Atea Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's forward indicators remain relatively invariable which may send shares a bit higher in August 2021. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more

Atea Pharmaceuticals Price Channel

Quick Ratio2.71
Fifty Two Week Low18.72
Target High Price35.00
Fifty Two Week High94.17
Target Low Price35.00

Atea Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  3,360  in Atea Pharmaceuticals on April 27, 2021 and sell it today you would lose (849.00)  from holding Atea Pharmaceuticals or give up 25.27% of portfolio value over 90 days. Atea Pharmaceuticals is currently does not generate positive expected returns and assumes 5.7941% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Atea Pharmaceuticals, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Atea Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 7.79 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.07 per unit of volatility.

Atea Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Atea Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Atea Pharmaceuticals, and traders can use it to determine the average amount a Atea Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0506

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsAVIR
Estimated Market Risk
 5.79
  actual daily
 
 49 %
of total potential
 
4949
Expected Return
 -0.29
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.05
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Atea Pharmaceuticals is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atea Pharmaceuticals by adding it to a well-diversified portfolio.

About Atea Pharmaceuticals Performance

To evaluate Atea Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Atea Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Atea Pharmaceuticals Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Atea Pharmaceuticals stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Atea Pharmaceuticals's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Return on Investment(18.80) (20.28) 
Return on Average Assets(0.025) (0.0269) 
Return on Average Equity(0.044) (0.0452) 
Return on Invested Capital 0.07  0.07 
Return on Sales(0.20) (0.22) 
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts. Atea Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Things to note about Atea Pharmaceuticals

Checking the ongoing alerts about Atea Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Atea Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Atea Pharmaceuticals Alerts

Equity Alerts and Improvement Suggestions

Atea Pharmaceuticals generates negative expected return over the last 90 days
Atea Pharmaceuticals has high historical volatility and very poor performance
Atea Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 48.63 M. Net Loss for the year was (10.95 M) with profit before overhead, payroll, taxes, and interest of 33.65 M.
Atea Pharmaceuticals has a poor financial position based on the latest SEC disclosures
About 58.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.biopharmadive.com: COVID-19 drug developer Adagio plans IPO to cap fast rise - BioPharma Dive
Please continue to Trending Equities. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
The market value of Atea Pharmaceuticals is measured differently than its book value, which is the value of Atea Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Atea Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Atea Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea Pharmaceuticals' market value can be influenced by many factors that don't directly affect Atea Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Atea Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.